Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ultrasound may spot preterm babies needing lung treatment earlier

NCT ID NCT05782569

Knowledge-focused Sponsor: South Tees Hospitals NHS Foundation Trust Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether chest ultrasound can predict which premature babies (born before 34 weeks) will need surfactant—a substance that helps their immature lungs work better. Doctors currently decide based on oxygen levels, which can delay treatment. Researchers performed lung ultrasounds on 86 babies in the first few days of life, but did not use the images for treatment decisions. The goal was to see if ultrasound scores could reliably predict the need for surfactant, potentially allowing earlier and more effective treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple, non-invasive way to decide which premature babies need surfactant early, potentially improving their breathing and reducing complications.
What could go wrong
This was a small, observational study (86 babies) that only recorded ultrasound images without using them for treatment decisions. The findings need confirmation in larger, interventional trials before changing practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

86 people

The number who actually took part.

Started

May 2023

Finished

Jun 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Recruiting the neonatal (Newborn) population. Currently there is no definite way of identifying which infant would need surfactant so this research would study study the value of lung ultrasound in predicting which infant would benefit from surfactant

Ages

23 to 34 weeks

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Gestational age ≤34 weeks based on last menstrual period or ultrasound dating. 2. Non-invasive respiratory support or low flow oxygen needing neonatal unit admission Exclusion Criteria: 1. Received surfactant before first LU (\<3hrs of life). 2. Major congenital malformations including congenital lung disease and congenital heart disease as ascertained by the medical team. 3. Infants receiving delivery room surfactant or required intubation shortly after admission. 4. Infants diagnosed with pneumothorax needing needle or chest tube drainage

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Infant, premature are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Premature Birth respiratory distress syndrome in premature infants

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Infant, premature

Contacts and locations

Locations

  • South Tees NHS Foundation Trust

    Middlesbrough, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.